Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.65
+0.35 (2.63%)
Nov 20, 2024, 4:00 PM EST - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $351.87 million as of November 21, 2024.
Market Cap
351.87M
Enterprise Value
138.57M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $351.87M, a decrease of -12.49%. That is a compound annual growth rate of -19.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 342.84M | -14.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 428.62M |
| Esperion Therapeutics | 423.63M |
| Aquestive Therapeutics | 423.07M |
| Revance Therapeutics | 418.56M |
| DocGo | 408.20M |
| Prime Medicine | 405.75M |
| KalVista Pharmaceuticals | 401.90M |
| Rigel Pharmaceuticals | 400.57M |